VST — Victory Square Technologies Share News
0.000.00%
Last trade - 00:00- CA$46.40m
- CA$38.37m
- CA$35.39m
Brief: Victory Square Provides Update On Hydreight And Healthcare Investments Following FDA Advisory Committee Recommendations On Peptide-Related Bulk Drug Substances
Brief: Victory Square Provides Update On Hydreight And Healthcare Investments Following FDA Advisory Committee Recommendations On Peptide-Related Bulk Drug Substances
Brief: Victory Square Technologies Declares Special Common Share Dividend Of Its Interest In Yocale.ai
Brief: Hydreight Technologies Signs Binding Letter Of Intent To Acquire Dynamic Iv Therapy Support Ai Agent
Brief: Victory Square Company Announces Access to Tirzepatide and GLP-1 Injections to its Weight Loss Portfolio
Advisory: Alert on Victory Square Technologies withdrawn
Brief: Victory Square Technologies To Issue Second Tranche Of Special Common Share Dividend Of Its Interest In Portfolio Company Fantasy 360 Technologies Inc In Dec. 2021
Brief: Victory Square Technologies Announces Immersive Tech Share Dividend Initiative For VST Shareholders
Brief: Victory Square Health Received Brazilian Anvisa Approval For 15 Minute Covid-19 Rapid Test For Sale In Brazil
Brief: Victory Square Says Received 2 Mln In Orders Of Its Safetest Covid-19 Test In Brazil
Brief: Victory Square Technologies's V2 Games Acquires Assets and IP of GameOn App Inc
Brief: Victory Square Technologies Says Receives Approval For Sale And Use Of Covid-19 Antibody Test For EU
Brief: Victory Square-Granted FDA Permission In U.S. To Commence Marketing, Sales& Distribution Under Emergency Use Authorization For Safetest Covid-19 Assay
Brief: Victory Square Enters Agreement to Acquire 23.1 Pct of Blockchain-Focused Fintech Co Cassia Research
Brief: Victory Square acquires 33 pct share of Personalized Biomarkers